LDLR and hepatocellular carcinoma: In the human hepatoma cell line HepG2, pinostrobin reduces the transcription of convertase subtilisin/kexin type 9 (PCSK9) by modulating FoxO3a, resulting in an increase in low-density lipoprotein (LDL) uptake via the LDL receptor (LDLR) [18].